HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ke Yao Selected Research

Fibrillin-1

8/2009[Computer construction and analysis of protein models of mutant fibrillin-1 gene in Marfan's syndrome].
11/2008Correlation of the recurrent FBN1 mutation (c.364C>T) with a unique phenotype in a Chinese patient with Marfan syndrome.
7/2007Novel FBN1 mutations associated with predominant ectopia lentis and marfanoid habitus in Chinese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ke Yao Research Topics

Disease

125Cataract (Cataracts)
04/2024 - 02/2002
40Neoplasms (Cancer)
05/2024 - 10/2003
20Inflammation (Inflammations)
05/2024 - 03/2011
15Carcinogenesis
11/2021 - 10/2003
14Glaucoma
01/2023 - 12/2002
10Wounds and Injuries (Trauma)
02/2024 - 07/2014
10Macular Degeneration (Age-Related Maculopathy)
11/2022 - 01/2011
10Colonic Neoplasms (Colon Cancer)
01/2021 - 04/2010
9Blindness (Hysterical Blindness)
02/2024 - 05/2013
9Ocular Hypertension (Glaucoma, Suspect)
02/2023 - 08/2011
8Dry Eye Syndromes (Dry Eye Syndrome)
04/2024 - 03/2015
8Endophthalmitis (Ophthalmia)
02/2023 - 12/2003
8Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2023 - 12/2002
8Myopia
01/2016 - 01/2002
7Infections
11/2023 - 10/2013
7Lung Neoplasms (Lung Cancer)
01/2021 - 10/2003
6Macular Edema
05/2022 - 09/2004
6Rupture
05/2021 - 04/2015
6Skin Neoplasms (Skin Cancer)
01/2020 - 12/2012
5Corneal Injuries
02/2024 - 01/2010
5Neoplasm Metastasis (Metastasis)
12/2023 - 01/2017
5Cicatrix (Scar)
11/2023 - 07/2012
5Capsule Opacification
05/2023 - 01/2014
5Keratitis
01/2023 - 01/2016
5Diabetic Retinopathy (Retinopathy, Diabetic)
11/2022 - 10/2009
5Hypoxia (Hypoxemia)
06/2020 - 10/2009
5Astigmatism
11/2017 - 01/2010
4Bacterial Infections (Bacterial Infection)
11/2023 - 01/2019
4Corneal Neovascularization
03/2023 - 05/2002
4Pterygium
12/2021 - 01/2008
4Pseudophakia
01/2012 - 05/2006
3Eye Diseases (Eye Disease)
05/2024 - 01/2023
3Melanoma (Melanoma, Malignant)
05/2024 - 12/2012
3Presbyopia
06/2023 - 07/2011
3Cysts
05/2023 - 11/2021
3Esophageal Squamous Cell Carcinoma
01/2023 - 01/2017
3Vascular Diseases (Vascular Disease)
09/2022 - 01/2021
3Ischemia
08/2022 - 10/2009
3Diabetes Mellitus
01/2022 - 04/2015
3Body Weight (Weight, Body)
01/2021 - 01/2014
3Retinal Detachment (Retinal Detachments)
02/2020 - 09/2002
3Hypertension (High Blood Pressure)
01/2018 - 04/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 10/2014
3Lymphatic Metastasis
01/2017 - 10/2003

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
02/2024 - 07/2003
28Crystallins (Crystallin)IBA
02/2024 - 07/2003
23Retinaldehyde (Retinal)IBA
12/2023 - 09/2004
9Capsules (Microcapsules)IBA
10/2023 - 04/2015
8Anti-Bacterial Agents (Antibiotics)IBA
11/2023 - 01/2017
7CollagenIBA
02/2024 - 01/2012
7Ophthalmic Solutions (Eye Drops)IBA
02/2023 - 09/2010
7Therapeutic UsesIBA
12/2022 - 01/2007
6DNA (Deoxyribonucleic Acid)IBA
12/2023 - 11/2008
6Phosphotransferases (Kinase)IBA
01/2023 - 12/2015
6LanosterolIBA
01/2023 - 12/2018
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2021 - 01/2012
5AlkaliesIBA
03/2023 - 05/2002
5bromfenacFDA Link
11/2022 - 01/2013
5Fluorescein (Funduscein)FDA LinkGeneric
04/2020 - 09/2008
5Epidermal Growth Factor (EGF)IBA
01/2020 - 01/2011
4LipidsIBA
01/2024 - 09/2022
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 09/2009
4Oxygen (Dioxygen)IBA
02/2022 - 07/2012
4CytokinesIBA
01/2021 - 03/2011
4Protein Kinases (Protein Kinase)IBA
01/2020 - 01/2017
4SolutionsIBA
01/2015 - 06/2003
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024 - 01/2018
3HydrogelsIBA
02/2024 - 01/2022
3Particulate MatterIBA
12/2023 - 12/2021
3EnzymesIBA
12/2023 - 01/2021
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 11/2020
3Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2023 - 12/2011
3Gatifloxacin (Zymar)FDA Link
02/2023 - 11/2009
3Air Pollutants (Pollutants, Air)IBA
01/2023 - 12/2017
3Codon (Codons)IBA
10/2022 - 01/2021
3Liposomes (Liposome)IBA
05/2022 - 06/2003
3Messenger RNA (mRNA)IBA
01/2022 - 07/2012
3ChitosanIBA
01/2022 - 07/2014
3SilverIBA
01/2021 - 01/2020
3Caspase 3 (Caspase-3)IBA
10/2020 - 07/2003
3GoldIBA
01/2020 - 09/2017

Therapy/Procedure

37Phacoemulsification
04/2024 - 12/2003
32Therapeutics
05/2024 - 01/2011
31Lasers (Laser)
04/2024 - 09/2002
21Intraocular Lenses (Intraocular Lens)
10/2023 - 01/2002
7Laser In Situ Keratomileusis (LASIK)
01/2016 - 03/2002
6Vitrectomy
11/2016 - 09/2004
6Intraocular Lens Implantation
03/2015 - 01/2004
5Drug Therapy (Chemotherapy)
05/2024 - 07/2014
5Refractive Surgical Procedures
06/2023 - 01/2012
5Lenses
10/2021 - 05/2002
5Cautery
01/2021 - 05/2002
5Sutures (Suture)
01/2014 - 01/2008
4Photothermal Therapy
01/2023 - 09/2017
4Chemoprevention
10/2021 - 09/2014
4Capsulorhexis
01/2021 - 01/2016
4Corneal Transplantation (Keratoplasty)
01/2012 - 01/2010
3Slit Lamp
11/2022 - 01/2011
3Photochemotherapy (Photodynamic Therapy)
11/2020 - 06/2007
3Telescopes
01/2020 - 03/2005